Pathfinder Bancorp announced Q3 2026 net income of $2.1 million, or $0.32 per diluted share, down from $2.7 million in Q2 but up from $626,000 in Q3 2025. The bank focused on resolving commercial credit issues and managing deposits with disciplined pricing, resulting in stable net interest income of $10.7 million. Loans and deposits slightly declined due to runoff of higher-cost deposits and loan maturities, while core deposits remained strong at 82.6% of total deposits. Pathfinder declared a $0.10 per share dividend and anticipates new commercial real estate loan production starting in Q4, supported by regional economic growth.
Pathfinder Bancorp's Q3 2026 financial results provide context for readers interested in financials. As of Nov 02, 2026 19:51 WIB, among 142 priced Financials-sector US stocks tradable on Pluang, 84 rose and 26 fell. Notable movers include WULF at USD 12.13 with a 3.41% increase, AVAT at USD 1.01 up 2.89%, and BTBT at USD 0.83 rising 2.70%.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
